India Pesticides Q2 FY27: revenue down 21.6% to Rs. 231 Cr, PAT down 41.7% to Rs. 18 Cr
Q2 FY27 revenue down 21.6% to Rs. 231 Cr, EBITDA down 38.0% and PAT down 41.7% to Rs. 18 Cr on soft demand and raw material volatility.
By ScoutQuest · · 2 min read
- Q2 FY27 Revenue
- Rs. 231 Cr, down 21.6%
- Q2 FY27 EBITDA
- Rs. 33 Cr with a 14.4% margin, down 38.0%
- Q2 FY27 PAT
- Rs. 18 Cr at 8.0%, down 41.7%
- Period
- Q2 and H1 FY2027
- Positioning
- India Pesticides presents itself as an advanced molecule based manufacturing platform supplying technicals to global clients, ranking among the top three global producers of certain technicals, with 28,200 MT consolidated technicals capacit
📉 The latest quarter was weaker year on year on a consolidated basis: Q2 FY27 revenue from operations was Rs. 231 Cr, down 21.6%, EBITDA Rs. 33 Cr with a 14.4% margin, down 38.0%, and PAT Rs. 18 Cr at 8.0%, down 41.7%. Management attributes the decline to softer overseas demand, deficient and erratic rainfall that cut herbicide application in India, higher employee expenses and volatile raw material prices. For H1 FY27 the company reports revenue of Rs. 487 Cr, down 15.9%, and PAT of Rs.…
📉 The balance sheet and cash metrics also moved the wrong way. Cash from operations for H1 FY27 was Rs. 48 (Rs. in Cr.) against Rs. 84 in H1 FY26, borrowings rose to Rs. 85 (Rs. in Cr.) from Rs. 41 a year earlier, and net cash fell to Rs. 36 (Rs. in Cr.) at 30th Sep 2026 from Rs. 98 a year earlier, even as total equity rose to Rs. 1,043 (Rs. in Cr.).
🔬 The company says it received Technical Equivalence approval for an insecticide in the United Kingdom and registration for a herbicide in Argentina during the quarter, which management says create opportunities to broaden the export portfolio; CARE Ratings reaffirmed its credit ratings. Management states its vision is a more diversified, globally competitive agrochemical business supported by R&D, integrated manufacturing and trusted customer relationships.
🏭 Management says it will pursue product registrations in regulated markets, deepen customer engagement and strengthen manufacturing capabilities, and lists process optimisation, backward integration and development of differentiated molecules as priorities. The presentation backs this with 2 R&D centres and 25 scientists, DSIR-recognised laboratories, and a Hamirpur facility the company says gives a clear pathway to 30,000 MTPA of additional capacity, with two of ten operating blocks currently…
Also from India Pesticides
India Pesticides Q2 FY27: revenue down 21.6% to Rs. 231 Cr, PAT down 41.7% to Rs. 18 Cr
4 Nov 2026
India Pesticides Ltd press release, Q2 FY27
4 Nov 2026
Board approves Q2 and H1 FY27 results; auditors' limited review conclusion is unmodified
3 Nov 2026
More numbers
- Revenue from operations, Q2 FY27₹ 231 Cr
- EBITDA, Q2 FY27₹ 33 Cr
- PAT, Q2 FY27₹ 18 Cr
- Revenue from operations YoY change, Q2 FY27(21.6%)
- EBITDA margin, Q2 FY2714.4%
- PAT margin, Q2 FY278.0%
- Revenue from operations, H1 FY27₹ 487 Cr
- Cash from operations, H1 FY2748 (Rs. in Cr.)
- Net cash, 30th Sep 202636 (Rs. in Cr.)
- Borrowings, 30th Sep 202685 (Rs. in Cr.)
- EPS, Q2 FY271.60
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.